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Abstract. 
 
Lumican, a prototypic leucine-rich pro-
teoglycan with keratan sulfate side chains, is a major 
component of the cornea, dermal, and muscle connec-
tive tissues. Mice homozygous for a null mutation in lu-
mican display skin laxity and fragility resembling cer-
tain types of Ehlers-Danlos syndrome. In addition, the 
mutant mice develop bilateral corneal opacification. 
The underlying connective tissue defect in the homozy-
gous mutants is deregulated growth of collagen fibrils 
with a significant proportion of abnormally thick col-
lagen fibrils in the skin and cornea as indicated by 
transmission electron microscopy. A highly organized 
and regularly spaced collagen fibril matrix typical of the 
normal cornea is also missing in these mutant mice. 
This study establishes a crucial role for lumican in the 
regulation of collagen assembly into fibrils in various 
connective tissues. Most importantly, these results pro-
vide a definitive link between a necessity for lumican in 
the development of a highly organized collagenous ma-
trix and corneal transparency.
 
C
 
ollagen
 
 architecture plays an important role in
optimal functioning of various extracellular ma-
trix–rich tissues such as skin, tendon, muscle con-
nective tissue, and cornea of the eye. Lumican is a keratan
sulfate (KS)
 
1
 
-carrying member of the leucine-rich proteogly-
can family (LRP) that colocalizes with fibrillar collagens in
these connective tissues (2, 7). Other LRP members are
decorin, biglycan, fibromodulin, epiphycan, osteoglycin,
and keratocan (10, 17). In in vitro collagen fibril–forming
assays, some of these proteoglycans inhibit the lateral
growth of spontaneously forming fibrils, and are thus im-
plicated in regulating certain aspects of collagen fibril
structure as extracellular matrix is deposited and assem-
bled in vivo (31, 34, 37, 45). Thus in the eye, corneal trans-
parency is proposed to arise from minimal scattering of in-
cident light by a lattice arrangement of uniformly thick
collagen fibrils maintained by LRP members (24, 31, 44).
The lumican core protein, without the keratan sulfate
side chains, is equally efficient in inhibiting in vitro col-
lagen fibrillogenesis, suggesting this function to be entirely
core protein mediated (31). Recombinant decorin core
protein fragments have also been shown to bind collagen
and affect collagen fibril formation in vitro (34). The leu-
cine-rich repeat motifs have been historically implied in in-
teractions with collagens. A recent study has identified the
sixth leucine motif of decorin as the major collagen I–bind-
ing site in vitro (21). For lumican, specific sites of interac-
tions with collagens have yet to be identified. The three-
dimensional structures of the LRP members have been
modeled based on the crystal structure of porcine ribonu-
clease inhibitor (20), which also contains these leucine mo-
tifs and shares 18% amino acid identity with the LRPs.
The LRP core proteins are envisioned as having an arch or
horse shoe shape with the glycosaminoglycan (GAG)
chains protruding from the convex surface, whereas the
concave surface is free to bind parallel collagen microfibrils
and regulate their lateral association (38, 46). However,
each LRP may bind to distinct sites along a collagen fibril
as suggested by immunoelectron microscopic localization
and biochemical studies (15, 37). Thus in vivo they are
likely to control different aspects of collagen morphology.
The GAG side chains of the proteoglycans retain water
and maintain normal tissue hydration. In the cornea the
KS–GAGs play a significant role. KS levels show a strong
correlation with acquisition of corneal transparency dur-
ing development and healing of stromal wounds (8, 9).
However, functions of each of these proteoglycans in
vivo remain to be elucidated. Subtle differences in their in-
teractions with collagens, GAG content and expression
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patterns in tissues would imply that, in addition to func-
tions that overlap, they may have evolved to serve certain
unique functions in different tissues.
To understand functions of lumican in vivo, we delin-
eated the effect of lumican deficiency on connective tis-
sues of mice homozygous for a lumican null mutation. The
mutant mice develop bilateral corneal opacification, dis-
play Ehlers-Danlos syndrome (EDS)-like skin laxity, and
some of the same collagen fibril anomalies that have been
described in EDS patients (40). Our results emphasize the
importance of these proteoglycan genes as “primary de-
fect” candidates for certain types of EDS and corneal dys-
trophies.
 
Materials and Methods
 
In Situ Hybridization
 
Embryos were fixed in 4% paraformaldehyde for 12–24 h, dehydrated,
embedded in paraffin, and then sectioned at 6 
 
m
 
m. For in situ hybridiza-
tion, a 324-bp mouse coding sequence PCR amplified from exon 2 of a
mouse lumican genomic clone was cloned into pBluescript and used to
synthesize an antisense riboprobe (33). Washes were carried out at 65
 
8
 
C.
 
Null Homozygous Mice
 
A replacement vector was constructed from an 11-kb mouse lumican ge-
nomic clone in 
 
l
 
 Fix II (premade mouse 129SVJ genomic DNA library;
Stratagene, La Jolla, CA) using the following steps. A Not–BamHI lumi-
can genomic insert, 5.5 kb in length, was subcloned into pBluescript from
the original 
 
l
 
 Fix II genomic clone. An EcoRI–EcoRI fragment of 1.6 kb,
containing exon 2 was deleted from this clone. A EcoRI–BamHI 1.33-kb
PGK-neo cassette in which the BamHI site was repaired by blunt-ending,
ligated to EcoRI linkers, and then digested with EcoRI, to obtain a 1.33-kb
insert with EcoRI ends. This 1.33-kb PGK-neo cassette, missing the 500-bp
poly(A) signal sequence at its 3
 
9
 
 end, was inserted into the EcoRI site of
the 5.5-kb Not–BamHI lumican genomic clone. Clones containing the
PGK-neo cassette in the 5
 
9
 
 to 3
 
9
 
 orientation downstream of the 2.6-kb
Not–EcoRI lumican genomic DNA segment were then selected (see Fig. 2
 
a
 
). This Not–BamHI lumican clone derivative has a lumican genomic
DNA segment of 2.6 kb to serve as the 5
 
9
 
 arm of homology in the final tar-
geting construct, a PGK neoA insert in the correct orientation and a 3
 
9
 
arm of homology of 1.4 kb. The latter 1.4-kb BamHI–XhoI genomic DNA
segment was replaced with a 5-kb BamHI–XhoI fragment from the 
 
l
 
 Fix
II genomic clone to obtain a longer 3
 
9
 
 arm of homology. Correct targeting
in the embryonic stem (ES) cell line CT 120#25 was detected by Southern
(DNA) hybridization of ES cell DNA digested with HindIII, BamHI (see
Fig. 2), SacI and NcoI (data not shown) and probed with an internal 2-kb
probe. The targeting frequency was 1/200. Blastocyst (CD-1 background)
injection and development of chimeric animals were performed according
to published methods (16).
A mixture of two primer pairs, one pair internally from E2 (forward
primer, 5
 
9
 
-CCTGAGGAATAACCAAATCGACC-3
 
9
 
 and reverse primer,
5
 
9
 
-AGGCAGCTTGCTCATCTGAATTG-3
 
9
 
), the second pair from the
pGKneo cassette (forward primer 5
 
9
 
-CATTCGACCACCAAGCGA-
AAC-3
 
9
 
 and reverse primer 5
 
9
 
-AGCTCTTCAGCAATATCACGGG-3
 
9
 
)
were used to amplify a 380-bp and a 300-bp product from the wild type
and mutant allele, respectively. All mice were housed in the animal care
facility of Case Western Reserve University according to IACUC ap-
proved protocols.
 
Immunoblotting
 
Total proteoglycan was extracted from 8 to 10 whole adult eyes in 4 M
guanidine HCl, 100 mM sodium acetate buffer, pH 6.0, containing the fol-
lowing protease inhibitors: 1 mM PMSF, 5 mM benzamidine HCl, 5 mM
iodoacetamide, 5 
 
m
 
g/ml leupeptin, and 5 
 
m
 
g/ml pepstatin (12). An aliquot
of the extracted and dialyzed sample was digested with keratanase (Sigma
Chemical Co., St. Louis, MO) for KSPG detection according to published
methods (36). Digested and undigested samples were resolved by SDS-
PAGE and transferred to nitrocellulose membrane. Lumican was identi-
fied using a rabbit antiserum generated against a synthetic peptide from
the NH
 
2
 
-terminal end spanning residues 20–37 of mouse lumican (Re-
search Genetics Inc., Huntsville, AL). Presence of decorin in the lumican
null mice was confirmed using LF113, a rabbit anti–mouse decorin antiserum
generated against a synthetic peptide spanning amino acid residues 36–49
of mouse decorin (13). Both antisera were used at a dilution of 1:2,000 and
a goat anti–rabbit secondary antibody (1:10,000) conjugated to HRP for
substrate detection with the SuperSignal Substrate Western blotting kit
(Pierce Chemical Co., Rockford, IL).
 
Skin Tension Test
 
Two tensile samples were prepared from the dorsal skin of 9-mo male
control (
 
n
 
 5 
 
5) and mutant mice (
 
n
 
 5 
 
5). The skin was harvested and
tested within 1 h of sacrifice. Thickness measurements were taken on a
small shaved area of the skin using a micrometer. Test samples were pro-
duced using a template with a gauge region of 10-mm wide by 20-mm
long. The long axis of the sample coincided with the superior–inferior di-
rection of the mouse. The samples were placed in a custom alignment jig
and the ends were clamped between two aluminium plates with a piece of
sandpaper glued to the surfaces. The tension tests were performed on an
Instron (Canton, MA) servohydraulic materials test machine and loaded
to failure in tension at a constant rate of 1 mm/s. Stress was determined by
normalizing the change in actuator displacement for initial sample length.
Data was collected at a sampling frequency of 50 Hz using LabView soft-
ware (National Instruments, Austin, TX). Differences in skin tensile prop-
erties between the control and mutant mice were analyzed by Student’s
 
t
 
 test.
 
Slit-Lamp Examination of Eyes
 
Eyes of anesthetized mice were examined and photographed using a verti-
cal slit-lamp biomicroscope (Marco, Jacksonville, FL). For the external
photographs, additional external light was oriented towards the mice. For
slit views, the lens was adjusted to 50
 
8
 
 angle. To photograph whole eyes
and slit-lamp views, Ektachrome 160T and 1600 (Eastman Kodak, Roch-
ester, NY) films were used, respectively.
 
Transmission Electron Microscopy
 
Small portions of tail and whole cornea from eight homozygous mutants,
two heterozygous, and four homozygous wild-type mice were fixed in
2.5% glutaraldehyde, 25 mM sodium acetate buffer, pH 5.7, containing
0.3 M MgCl
 
2
 
, and 0.05% cuprolinic blue (39). Thin sections, with or with-
out further uranyl acetate staining were examined in an electron micro-
scope (100CX; JEOL USA Inc., Peabody, MA). Diameter of 100 to 250
fibrils were measured manually.
 
Results
 
Expression by In Situ Hybridization
 
During mouse embryonic development, lumican transcript is
detectable by in situ hybridization as early as E9.5 in all mes-
enchymal tissues (Fig. 1 
 
a
 
). By E13.5 stage lumican mRNA
is abundant throughout the corneal stroma, extrinsic ocu-
lar muscles, and to a lesser extent in the sclera of the eye
(Fig. 1 
 
b
 
), as well as the subepithelial dermis (Fig. 1 
 
c
 
). It is
also expressed in the perichondrium of developing rib pri-
mordia, developing circular and longitudinal muscles of
the gut (data not shown). In the developing heart, a strong
signal for lumican message is apparent in the leaflets of the
pulmonary and aortic valves (Fig. 1 
 
d
 
). Expression of lumi-
can in early stages of development implies a role in the migra-
tion/proliferation of mesenchymal cells and in the forma-
tion of an embryonic collagenous connective tissue matrix.
 
Gene Targeting at the Lumican Locus
 
A replacement gene targeting vector (Fig. 2 
 
a
 
) was de-
signed such that a 3-kb EcoRI–BamHI segment contain-
ing all of exon 2, the largest of the three exons was re- 
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placed with a 1.33-kb PGKneo expression cassette for
positive selection of ES cells. The 500-bp poly(A) signal
sequence was deleted from the original 1.8-kb PGKneo
cassette so that correct transcription of the cassette would
be contingent upon the presence of a chromosomal
poly(A) signal downstream of the construct. Correctly tar-
geted clones were identified by diagnostic Southern hy-
bridization using an internal probe and several restriction
enzymes with sites outside the vector DNA (Fig. 2 
 
b
 
). Germ-
line transmission of the mutated lumican allele, targeted
mutation 1 Sc (
 
lum
 
tm1Sc
 
), was achieved by mating founder
chimeras generated by injecting heterozygous ES cells into
eight-cell CD1 host embryos. Heterozygous 
 
lum
 
1
 
/
 
lum
 
tm1Sc
 
CD-1 mice were intercrossed to develop homozygous
 
lum
 
tm1Sc
 
/
 
lum
 
tm1Sc
 
 mice. The mice were genotyped by PCR
analysis (Fig. 2 
 
c
 
).
 
Homozygous Lumican Null Mutants Are Viable
 
The homozygous mutant mice were born alive, in the ex-
pected Mendelian ratio (
 
n
 
 5 
 
122; 
 
lum
 
1
 
/
 
lum
 
1
 
 
 
5 
 
26%,
 
lum
 
1
 
/
 
lum
 
tm1/Sc 
 
5 
 
50%, 
 
lum
 
tm1Sc
 
/
 
lum
 
tm1Sc 
 
5 
 
24%), and were
fertile. Approximately 10–15% of the 
 
lum
 
tm1Sc
 
/
 
lum
 
tm1Sc
 
mice were significantly smaller at birth, weighing 70–80%
of the body weight of heterozygous or wild-type litter-
mates. Western blot analysis of total protein from extracts
of whole eyes indicated no expression of lumican in
 
lum
 
tm1Sc
 
 
 
homozygous mice indicating that 
 
lum
 
tm1Sc
 
 is a null
allele (Fig. 2 
 
d
 
).
The lumican gene localizes to the same general region as
decorin, a related LRP member, on distal mouse chromo-
some 10 (6, 17). Therefore, a targeted deletion at the lumi-
can locus could conceivably disrupt decorin gene expres-
sion. To exclude this possibility we determined the presence
of the decorin core protein in the lumican null mutants.
Using LF113, an anti-decorin (murine) antibody (13), in
Western blots on total proteoglycans extracted from whole
eyes, we confirmed that lumican-deficient mice have nor-
mal levels of decorin (data not shown).
Routine histological examinations of null mice failed to
detect major cardiac valvular anomalies (data not shown)
although lumican is expressed fairly early in these tissues
Figure 1. Lumican expression
during mouse embryonic de-
velopment. In situ hybridiza-
tion analysis. (a) Sagittal sec-
tion of E.9.5. Lumican is
expressed at high levels in
head (arrow) and lateral mes-
enchyme (arrowhead). (b)
Transverse section of E13.5
embryo. At E13.5 lumican ex-
pression is focused in the sub-
epithelial dermis of eyelid area
(asterisk), cornea (arrowhead),
with  lesser amounts in the
sclera (arrow). The lens and
retina do not express lumican.
(c) Section through E15.5
stage dorsal skin. Top panel is
a bright field view of a tolui-
dine blue–stained section, and
bottom panel is a dark field
view of same section showing
silver grain deposits. Note that
darkly stained epidermal layer
(Ep) does not contain lumican
mRNA. Dermal layer (Dm)
displays a strong signal for lu-
mican transcript. No lumican
mRNA in central canal in
sacro-coccygeal region of spi-
nal cord (Sp). (d) Parasagittal
section through E15.5 embryo
showing heart pulmonary (P)
and aortic valve (A) leaflets
with strong signal for lumican
transcript. Bars, 100 mm. 
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(Fig. 1 
 
d
 
). Lumican is also expressed in the developing gas-
trointestinal tract, however, intestinal sections of adult mice
revealed normal tissue organization (data not shown). Ad-
ditionally, development of the corneal stroma (between
E13.5 and E16.5 stages, data not shown) appeared largely
unaffected although lumican is expressed in the early
stages of corneal development (Fig. 1 
 
b
 
).
 
Reduced Tensile Strength of Skin from
lum
 
tm1Sc
 
/lum
 
tm1Sc
 
 Mice
 
The null mutants had extremely loose and fragile skin ap-
parent during routine handling of the mice. Decorin-defi-
cient mice developed recently also exhibited similar skin
anomalies and reduced load to failure in tension tests (12).
We measured the tensile strength of freshly isolated skin
samples from 10 9-mo-old animals, 5 wild type, and 5 lumi-
can-deficient mice. Mutant mice without any visible le-
sions were chosen for skin testing. Test samples were pro-
duced in duplicate using a template with a gauge region
10-mm wide by 20-mm long. Stress, in Newtons/mm
 
2
 
 (N/
mm
 
2
 
) was determined by normalizing the load for initial
cross sectional area, and strain was determined by normal-
izing the change in actuator displacement for initial sam-
ple length. The stress versus strain curves revealed signifi-
cant differences in skin properties between mutant and
wild type (Fig. 3 
 
a
 
). First, the modulus or the slope of the
linear portion of the stress-strain curve of mutant skin (4.2 
 
6
 
1.6 N/mm
 
2
 
) was 83% (
 
P
 
 , 
 
0.0004) lower than modulus of
wild-type mouse skin (25.4 
 
6
 
 7.9 N/mm
 
2
 
). This indicates
that the lumican-null mutation causes a dramatic increase
in skin compliance. Second, the strength of the lumican-
deficient skin was compromised greatly (Fig. 3 
 
b
 
): skin
from mutant mice failed at 1.15 
 
6
 
 0.39 N/mm
 
2
 
, whereas
the wild-type skin samples failed at 8.28 
 
6
 
 1.04 N/mm
 
2
 
.
This 86% (
 
P
 
 
 
, 
 
0.0001) reduction in tensile strength of the
lumican-deficient skin is consistent with the increased inci-
dence of skin lesions in the mutants.
Trichrome-stained sections of skin samples taken from
dorsal and ventral areas of adult wild-type and null mutant
mice (non-lesioned areas sampled in the mutants) re-
vealed disorganized and a more loosely arranged dermal
connective tissue (stained blue) in the mutants (Fig. 4, 
 
b
 
and 
 
d, arrowhead). In wild-type animals dermal fibroblasts
Figure 2. Gene targeting at the lum locus. Exons
are marked as E1, E2, and E3. (a) Diagram of
the wild-type lum1 allele, targeting vector, and
targeted lumtm1Sc allele. Correct targeting should
replace the 3-kb EcoRI–BamHI segment con-
taining exon 2 (E2) with the 1.33-kb pGKneo
cassette for positive selection. (b) Diagnostic
Southern hybridization on ES clone DNA. Pres-
ence of a 4.5-kb BamHI and an 11-kb HindIII
fragment indicates one correctly targeted allele.
(c) PCR analysis of offsprings from heterozygous
matings. (d) Western blot analysis on total pro-
tein extracted from whole eyes of lumtm1Sc/
lumtm1Sc (2/2) and lum1/lumtm1Sc ( 1 / 2 ) mice.
Undigested extract from heterozygous mice
show a broad band at 65–90 kD, indicating the
presence of lumican. Lack of a sharp band is due
to heterogenous KS modification of lumican. Af-
ter keratanase treatment and removal of most of
the KS a sharper and faster migrating band re-
sults, a characteristic feature of KS proteogly-
cans. The lumtm1Sc/lumtm1Sc tissue lacks any im-
munoreactive material confirming the absence of
any lumican gene product.
Figure 3. Skin tensile stress-strain
measurements. (a) Representative ten-
sile stress-strain curves for skin samples
from wild type (1/1) and lumtm1Sc ho-
mozygous null mutants (2/2), n 5 5 for
each genotype. Tension tests were per-
formed in duplicate on freshly isolated
skin samples with a 10 3 20-mm gauge
region from the dorsal surface of each
animal. Samples were loaded to failure
in tension at a constant rate of 1 mm/s
using an Instron servohydraulic materi-
als test machine. Stress in N/mm2 was
plotted versus the strain. Note the signif-
icant reduction in both the modulus and the stress to failure in the 2/2 animals. (b) Tensile strength in wild type (1/1) and lumtm1Sc ho-
mozygous null mutants (2/2). The average tensile strength or maximum stress in the (2/2) skin was 86% lower than the wild-type (1/1)
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are aligned more in parallel to the epithelial layer (Fig. 4, a
and  c). In the mutants, the fibroblasts appear poorly
aligned (Fig. 4, b and d, arrows). Heterozygous mice do
not harbor any of these phenotypic abnormalities.
Corneal Opacification in the Absence of Lumican
Lumtm1Sc homozygous mice were examined for loss of cor-
neal clarity by slit lamp biomicroscopy to assess lumican’s
role in regulating corneal transparency. Out of 51 lumtm1Sc/
lumtm1Sc mice, between the ages of 5 to 34 wk, 44 displayed
bilateral corneal clouding, with a peripheral ring-like clear
zone, a characteristic feature of many human corneal stro-
mal dystrophies (5). We scored corneal clouding as 11
(clouding barely detectable) to 41 (total opacification un-
til no iris details visible). The maximum opacification asso-
ciated with the lumtm1Sc null phenotype was 3.51 as shown
in a full view of the eye (Fig. 5 b). The cornea of wild-type
and heterozygous mice (not shown) appeared clear with
normal stromal granularity (Fig. 5, a and c; arrow in c),
whereas the stroma of lumtm1Sc/lumtm1Sc mice appeared
uniformly hazy (Fig. 5 b) and opalescent in slit view result-
ing from increased scattering of light (Fig. 5 d, arrowhead).
The corneal clouding phenotype appeared to be clearly
age dependent; the 7 out of the 51 that had clear corneas
during our initial examination were between the ages of 5
and 6 wk, by 8–12 wk most of the mice had cloudy corneas.
Follow-up eye examinations over a period of 4 mo were
performed on 14 additional mutants and age-matched wild
type. Over time the corneal opacification showed an in-
crease; in 11 out of 14, opacity increased from a level of 0
or 1 to 3.5 (Fig. 6). However, all of the older mutants ex-
amined did not display maximal clouding of corneas. The
variable expressivity of the corneal clouding phenotype
may be due to the effect of other modifier genes. Whether
this variable expressivity extends to other collagenous tis-
sues is currently being investigated. Limited analysis of
lumtm1Sc homozygosity on an inbred 129/Sv1Tyr1p genetic
background also showed corneal clouding in adult mice.
Further analyses of the lumtm1Sc mutation in 129/Sv1Tyr1p
mice are underway to address the impact of genetic back-
ground on age of onset.
Abnormal Collagen Fibril Morphology
To determine whether abnormal collagen architecture un-
derlies the skin and corneal manifestations, corneal and
tail sections (skin and tendon areas) of age matched mice
were examined by transmission electron microscopy. In
wild-type (Fig. 7, a and e) and heterozygous mice (not
shown), the corneal collagen fibrils were uniformly thin in
Figure 4. Histological analyses on skin alterations. Sections through skin from dorsal (a and b) and ventral (c and d) surfaces. Wild-type
animals (1/1) shown in a and c and lumican null mutants (2/2) shown in b and d. The sections were trichrome stained in which the
connective tissue, collagens primarily stain blue. Note disoriented fibroblasts (arrows) and open spaces (arrowheads) in the dermis of b
and d. Bar, 50 mm.The Journal of Cell Biology, Volume 141, 1998 1282
cross section (diameter distribution 5 20–40 nm) and
closely packed. In the null mutant mouse corneas (Fig. 7, b
and f) three differences were obvious. First, in addition to
fibrils of normal diameter there were thicker fibrils. Mean
fibril diameter was 47 6 1.4 nm in mutants and 30 6 1.7
nm in wild type (Fig. 7, f and e, respectively). Second, a
cross sectional view revealed many irregular shaped fibrils,
which were most likely due to abnormal lateral fusion of
fibrils in the null mutants (Fig. 7 b, arrow). Third, there
was an increase in the interfibrillar spacing. Another fea-
ture of the mutant corneas was a dramatic disorganization
in the arrangement of collagen fibrils and keratocytes evi-
dent under low magnification electron microscopy (not
shown). In lumtm1Sc/lumtm1Sc tail preparations, dermal areas
also displayed increased interfibrillar spacing and a wide
range of fibril diameter in cross section (50–150 nm in wild
type, and 33–250 nm in mutants; Fig. 7, g and h). Com-
pared with corneal collagen however, tail skin collagen
fibrils were less affected by the lumican null mutation
(mean fibril diameter was 90 6 1 in wild type and 107 6 7
in null mutants). Larger and abnormally shaped collagen
fibrils in cross section were also evident in electron micro-
graphs of dorsal skin preparations (not shown). Interest-
ingly, although lateral fusion of collagen fibrils were fre-
quent in dermis and tendon of decorin-deficient mice their
corneal collagen were normal (12).
Figure 5. Eye examination
for corneal clarity. Full view
photobiomicroscopy of wild
type (a) and lumtm1Sc ho-
mozygous mutants (b) eyes.
Wild-type  mice show clear
corneas through which iris de-
tails can be seen (a). A con-
tinuous cloudiness with a
clear ringlike peripheral zone
is noticeable in the null mu-
tant (b). Slit-lamp photo-
biomicrography of wild type
(c) and lumtm1Sc homozygous
mutant (d). Note clear beam
with normal granularity in c
and enhanced brightness be-
cause of increased light scat-
tering and extensive granular
material in d.
Figure 6. Changes in corneal
opacification over time. Out
of 14 lumtm1Sc homozygous
mutants that were given fol-
low-up eye exams over 7–8
mo, progression in opacity is
shown for four mutants here.
All 14 animals showed in-
crease in opacity over time.Chakravarti et al. Abnormal Collagen, and Corneal Opacity in Lumican Null Mice 1283
Discussion
Mice homozygous for a null mutation of the lumican gene
are viable, with major effects on two distinct connective
tissues: the skin and cornea. The mutant mice display skin
laxity and fragility with easy bruising of the skin. Corneal
development in the mutant mice appear normal but the
cornea loses transparency between 4 and 5 wk of age. To
elucidate the underlying defect that leads to this pheno-
type we focused on understanding the changes in the ar-
chitecture of the lumican-deficient collagenous extracellu-
lar matrix of these connective tissues.
Fibrillar collagens constitute the bulk of all connective
tissues and provide the biomechanical support for optimal
functioning of these tissues. A large number of common
and rare connective tissue disorders have been linked to
altered collagen morphology. Not surprisingly much of
these studies have concentrated on identifying collagen
gene defects (22, 25). However, assembly and final proper-
ties of the fibrillar collagen matrix is also influenced by
other collagen types such as collagen type V (1) and asso-
ciated glycoproteins and proteoglycans. In vitro collagen-
binding and fibrillogenesis assays (31, 34, 35, 45) suggest
strongly that in vivo molecular interactions of lumican and
other LRP members with collagen fibrils are likely to in-
fluence collagen architecture and overall tissue biome-
chanics. The phenotypes of the lumican-deficient mice
Figure 7. Transmission elec-
tron micrography of cornea
(a and b) and tail dermis (c
and d) collagen preparations
(17). (a and c) Homozygous
wild type, and (b and d)
Lumtm1Sc homozygous. Note
larger abnormal shaped fibrils
in cross section (arrowhead)
in b and d. Fibril diameter
frequency (e–h). Homozy-
gous wild-type cornea and
tail collagen (e and g) and
lumtm1Sc homozygous cornea
and tail collagen (f and h).
Bar, 0.2 mm.The Journal of Cell Biology, Volume 141, 1998 1284
presented in this study and the decorin-deficient mice by
Danielson and coworkers (12) clearly bring into focus the
LRPs as major regulators of collagen fibril assembly and
as likely primary causes for many of these connective tis-
sue disorders.
Lumican Regulates Collagen Fibril Assembly
Lumican deficiency has a profound effect on the structure
of collagen fibrils as evidenced by transmission electron
microscopy on corneal and tail skin sections. The main
features of the altered collagen morphology are the pres-
ence of thicker fibrils in addition to fibrils of normal diam-
eter, with frequent lateral fusions of fibrils, increased and
non-uniform interfibrillar spacing. The emerging notion is
that the LRP core proteins bind to the surface of collagen
fibrils as they form by lateral association of trimeric collagen
molecules. The LRPs maintain narrow diameter and dis-
courage lateral fusion of fibrils. Laterally fused fibrils may
be somewhat displaced in space, thus locally increasing
interfibrillar space in the mutants. Absence of lumican
may also disturb normal GAG levels, or lead to overex-
pression of other collagens or proteoglycans that contrib-
ute to increased interfibrillar spacing. However, by immu-
noblot analyses, we found that the lumican null mice make
normal levels of the decorin core protein.
Skin Fragility in Lumtm1Sc Homozygous Mice
There is a remarkable association of skin laxity and fragil-
ity with the targeted lumican null mutation seen in this
study, and in the targeted decorin and more recently de-
veloped thrombospondin 2 null mutations (12, 23). We
found a major disruption in the biomechanical properties
of skin in the lumican null mutants. Compared with lumi-
can wild type, the lumican-deficient mice exhibited an
eightfold reduction in the load to failure in tension tests.
Decorin-deficient mice, on the other hand, developed a
fourfold reduction in the load to failure compared with
their wild-type background (12). Our lumican-deficient
skin tensile test results were independent of any differ-
ences in skin thickness between the mutant and wild-type
animals and, therefore, represent a direct biomechanical
measure of tissue-level alterations associated with the mu-
tation. At the histological level, lumican-deficient skin tis-
sue displayed disorganized and loosely packed collagen fi-
bers. In particular, in the subepithelial areas there seemed
to be a lack of orientation in the collagen fibers and fibro-
blasts. These histological anomalies correlate well with the
electron microscopically observed poorly organized col-
lagen matrix, increased interfibrillar spacing and altered
fibril morphology. Both decorin and thrombospondin-
deficient mice displayed similar structural anomalies of
the skin as well (12, 23). From a biomechanical standpoint,
the reduced tensile strength of the lumican-deficient skin
is due to a disruption in the normal transmission of load
from the matrix to the collagen fibrils and, thus a direct
consequence of the altered collagen morphology (11, 27, 29).
EDS, a highly heterogenous group of connective tissue
disorders is also characterized by skin laxity and fragility,
and displays some of the same collagen fibril anomalies
seen in the lumican null mice (30, 40). Mutations in the
fibrillar collagen genes are leading causes for several types
of EDS. Additionally, mutations in enzymes involved in
processing of nascent collagens, and those that may aid
fibril assembly, are beginning to be recognized as causes of
EDS. Mutations in lumican and other LRPs will fall in this
last category, which includes recent detection of mutations
in COL5A1 gene (42) and Tenascin-X (3).
Lumican Required for Postnatal Corneal Development 
and Maturation
The effect of lumican deficiency on the cornea is quite dra-
matic: initially clear corneas become cloudy postnatally at
a certain age in these mice. This has important implica-
tions for lumican’s role in acquiring and maintaining cor-
neal transparency. Our results show that although lumican
is not necessary for early embryonic stages of corneal de-
velopment, it is essential for postnatal maturation of the
cornea. An understanding of how collagen fibrils are as-
sembled during corneal development will answer the ques-
tion of why, as in many human corneal dystrophies, cor-
neal clouding in the lumican null mutants display an age
dependence. Keeping pace with the rest of the organism,
the cornea continues to increase in diameter for sometime
after birth. This process requires increased synthesis of
collagen, proteoglycans, and degradative remodeling of
the extracellular matrix (32). Lumican appears to play a
critical role during this post natal assembly and organiza-
tion of collagen fibrils in the cornea.
Lumican deficiency in the cornea poses two problems:
loss of core protein as well as its KS functions. Whether lu-
mican deficiency affects overall corneal KS levels and
whether some of the other lumican-like core proteins are
abnormally modified with KS chains have to be carefully
evaluated. Indeed a preliminary investigation of GAGs in
the lumican-deficient mice suggests a reduction in GAG
levels (data not shown). The corneal clouding may thus be
the result of multiple interacting factors: abnormal fibril
assembly, lateral fusion of fibrils resulting from lumican
core protein deficiency, and altered interfibrillar spacing
because of an absence of lumican-associated KS chains. In
decorin-deficient mice, which reportedly have normal cor-
neal collagen architecture (12), it is possible that other LRP
members such as lumican complement decorin core pro-
tein functions in the eye. Furthermore, chondroitin-4-sul-
fate, the GAG side chain of decorin is believed to play a
minor role in corneal transparency (8, 9). Therefore, any
reduction in its level in the decorin null mice is less likely
to affect corneal transparency.
Lumtm1Sc Homozygous Corneal Phenotype and Human 
Corneal Stromal Dystrophies
The  lumtm1Sc corneal phenotype may be compared with
two broad categories of corneal stromal dystrophies. Per-
turbed GAG levels in lumtm1Sc homozygosity is a feature
that biochemically resembles type I and type II macular
corneal dystrophies (MCD I and II), which also show pro-
gessive bilateral corneal clouding. Antigenic KS is absent
from serum and cornea in MCD I whereas other GAGs
may be affected in MCD II (19, 26). Additionally, in MCD
non-glycanated core proteins of the proteoglycans precipi-
tate and contribute to the pathogenesis. Both MCD typesChakravarti et al. Abnormal Collagen, and Corneal Opacity in Lumican Null Mice 1285
localize to human chromosome 16q22 (43). Whereas lumi-
can localizes to human chromosome 12q21.3-q22 (7), four
other stromal dystrophies with amyloid type deposits that
somewhat resemble the lumican null corneal phenotype
are all because of mutations in the gene encoding kerato-
epithelin on chromosome 5q31.1 (28). The second category
includes stromal dystrophies with altered collagen fibril man-
ifestations (see online Mendelian Inheritance in Man data-
base on the World Wide Web at http://www3.ncbi.nlm.nih.gov/
omim/) (4, 25). Lack of lumican–collagen interactions and
resulting disruption of collagen fibril assembly mimics the
second category. The recessive eye bleb mutation in
mouse, with clear blistering and eventual corneal opacity
also maps to distal 10 and could be due to mutations in lu-
mican, or keratocan this region, or one of the other related
LRP that map to this region (12a, 14). A class of corneal
dystrophies that map on human chromosome 12q, same
chromosome as lumican, are dominant and recessive forms
of Cornea Plana Congenita, involving corneal maldevelop-
ment. However, these are phenotypically quite different
from the lumican null corneas, and may be due to keratin
gene defects (41). Meesmann’s corneal dystrophy, a defect
of the corneal epithelium, has recently been shown to be
resulting from mutations in the keratin K3 and k12 genes
on chromosome 12q and 17q, respectively (18).
Conclusions
In conclusion we have generated lumican null homozy-
gous mutants by gene targeting in the mouse. Lumican de-
ficiency causes skin laxity and fragility resembling EDS
and will lead to mouse models for specific types of EDS.
By comparing the targeted null mutation phenotypes of
lumican, decorin (12), and thrombospondin-2 (23) we will
gain further insights into how these proteoglycans and gly-
coproteins regulate fibril assembly in vivo and affect func-
tions of different organs and tissues. Although tissue ultra-
structure and skin tensile strength is affected in all three
null mutants, the lumican null mutation also disrupts cor-
neal transparency. Corneal proteoglycans have been his-
torically implicated in maintaining a collagen architecture
that is conducive to corneal transparency. Our study pro-
vides the first in vivo evidence that loss of lumican, one
such proteoglycan from the cornea, causes deregulation of
collagen fibril assembly and corneal opacification. The
lumtm1Sc/lumtm1Sc mice will serve as an in vivo system for
understanding the basis of corneal transparency.
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